CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BF Biosciences Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BF Biosciences Ltd
5 KM Sunder Raiwind Road
Phone: +92 4236026700p:+92 4236026700 Lahore, 46000  Pakistan Ticker: BFBIOBFBIO

Business Summary
BF Biosciences Ltd is a diversified biotech pharmaceutical company. The principal activity of the Company is the import, manufacturing, and sale of pharmaceutical products. Its products include Vorif 200mg, Vorif 50mg, Icon 100mg, Eterna 50mg, Apreon, Centaurus, Genesis, Azobar 500mg, Azobar 250mg, Azobar Suspension 30ml, Azobar Suspension 15ml, Acylex Suspension 60ml, Acylex Ointment 10 gram, Acylex Ointment 5 gram, Acylex 800mg, Acylex 400mg, Acylex 200mg, Hecolin, Ferulin N, Ferulin R, Ferulin 70/30, Oxaltie Injection 100mg, Oxaltie Injection 50mg, Donataxel 80mg, Donataxel 20mg, Panataxel 300mg, Panataxel 150mg, Panataxel 100mg, Panataxel 30mg, Noxane 80mg, Noxane 60mg, Esomega 40mg, Noxane 40mg, Omega 40mg, Noxane 20mg, Eritrogen Injection Pre-filled Synringe 10000 IU, Eritrogen Injection Pre-filled Synringe 4000 IU, Eritrogen Injection 10000 IU, Eritrogen Injection 4000 IU, Novapressin Injection, Filgen Injection, INF -A Injection, INF Injection, and Eritrogen Injection 2000 IU.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/20246/30/2024-----

General Information
Number of Employees: 386 (As of 6/30/2024)
Outstanding Shares: 88,333,334 (As of 9/30/2024)
Stock Exchange: PSX
Fax Number: +92 4236026701


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 29, 2025